Skip to content

Drs. Ghobrial and Nadeem discuss results from the phase II CAR-PRISM trial
FDA approves oral combo for newly diagnosed AML
FDA grants accelerated approval to sonrotoclax for relapsed or refractory mantle cell lymphoma
Gene editing technology may improve toxicity, efficacy of transplants for AML, MDS
5-year BRUIN data show pirtobrutinib induces response in previously treated Waldenström macroglobulinemia

Join SOHO

Follow Us :

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Current Issue
  - Past Issues
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
- Past Sessions
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

About Us

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Join SOHO

Categories

FDA approves ruxolitinib extended-release tablets for MF, PV, and GVHD

Cellular Therapy

FDA approves ruxolitinib extended-release tablets for MF, PV, and GVHD

Leukemia

FDA approves ruxolitinib extended-release tablets for MF, PV, and GVHD

Lymphoma

FDA approves ruxolitinib extended-release tablets for MF, PV, and GVHD

Multiple Myeloma

FDA approves ruxolitinib extended-release tablets for MF, PV, and GVHD

Myelodysplastic Syndromes

FDA approves ruxolitinib extended-release tablets for MF, PV, and GVHD

Myeloproliferative Neoplasms

Contact Info

[email protected] 1.281.364.7387

Follow Us

May 16, 2026

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Current Issue
  - Past Issues
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
- Past Sessions
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

SOHO Insider Hem/Onc Library Myeloproliferative Neoplasms

MPN News

Silver,Spring,,Md,,Usa,-,June,25,,2022:,The,Fda

Myeloproliferative Neoplasms Polycythemia Vera Primary Myelofibrosis News

FDA approves ruxolitinib extended-release tablets for MF, PV, and GVHD

by SOHO Insider Editors
May 5, 2026
0 Comments

SOHO 2026 Leukemia Lymphoma Multiple Myeloma Myelodysplastic Syndromes Myeloproliferative Neoplasms News Society Updates

Don’t miss SOHO 2026 poster walks

by Leah Sherwood
April 7, 2026
0 Comments

SOHO 2026 Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Chronic Lymphocytic Leukemia Chronic Myeloid Leukemia Aggressive B-Cell Lymphomas Indolent B-Cell Lymphomas Mantle Cell Lymphoma T-Cell Lymphoma Multiple Myeloma Myelodysplastic Syndromes Myeloproliferative Neoplasms Society Updates

Registration now open for SOHO 2026, receive early bird rates until June 10

by SOHO Insider Editors
March 31, 2026
0 Comments

New community oncology sessions

Community Oncology News Leukemia Acute Lymphoblastic Leukemia Lymphoma Aggressive B-Cell Lymphomas Multiple Myeloma Myelodysplastic Syndromes Myeloproliferative Neoplasms News

Drs. Krish Patel and Gwen Nichols join SOHO Insider community oncology series

by SOHO Insider Editors
March 16, 2026
0 Comments

FDA

Myeloproliferative Neoplasms Polycythemia Vera News

FDA grants priority review to rusfertide in polycythemia vera

by SOHO Insider Editors
March 4, 2026
0 Comments

Yu-Hung Wang

SOHO Asia 2026 Ambassador Program Multiple Myeloma Myelodysplastic Syndromes Myeloproliferative Neoplasms News

Yu-Hung Wang, MD, PhD, discusses unmet needs in myeloid neoplasms at SOHO Asia

by SOHO Insider Editors
February 10, 2026
0 Comments

Smoldering Multiple Myeloma Incidence Trends

Multiple Myeloma Myeloproliferative Neoplasms News

Smoldering MM trends data show increased incidence in certain patient populations

by Kerri Fitzgerald
February 3, 2026
0 Comments

FDA

Myeloproliferative Neoplasms Primary Myelofibrosis News

FDA grants zavabresib orphan drug designation in myelofibrosis

by SOHO Insider Editors
January 27, 2026
0 Comments

Myeloproliferative Neoplasms SOHO Insider Podcast

Advances in essential thrombocythemia with Drs. Kuykendall, Tremblay

by Leah Sherwood
January 15, 2026
0 Comments

Phase 1 PROMISE Trial Updates

Trending now ASH 2025 Myeloproliferative Neoplasms Primary Myelofibrosis

Adam Mead, MD, on interim phase 1 PROMise trial results in myelofibrosis

by SOHO Insider Editors
December 31, 2025
0 Comments

1
2
3

Top Categories

Cellular Therapy

71

Leukemia

110

Lymphoma

122

Multiple Myeloma

94

Myelodysplastic Syndromes

38

Myeloproliferative Neoplasms

22

POPULAR NEWS

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

About

About Us / Editorial Board

Advertising

Contact Us

Support SOHO

Categories

Adam Mead, MD, on interim phase 1 PROMise trial results in myelofibrosis

Cellular Therapy

Adam Mead, MD, on interim phase 1 PROMise trial results in myelofibrosis

Leukemia

Adam Mead, MD, on interim phase 1 PROMise trial results in myelofibrosis

Lymphoma

Adam Mead, MD, on interim phase 1 PROMise trial results in myelofibrosis

Multiple Myeloma

Adam Mead, MD, on interim phase 1 PROMise trial results in myelofibrosis

Myelodysplastic Syndromes

Adam Mead, MD, on interim phase 1 PROMise trial results in myelofibrosis

Myeloproliferative Neoplasms

Subscribe

Recent Posts

Drs. Ghobrial and Nadeem discuss results from the phase II CAR-PRISM trial

FDA laptop

FDA approves oral combo for newly diagnosed AML

FDA grants accelerated approval to sonrotoclax for relapsed or refractory mantle cell lymphoma

Copyright © 2026 Society of Hematologic Oncology, All rights reserved.